EligibleTrials

Clinical trials recruiting for Oligometastatic Prostate Carcinoma

5
Recruiting trials
5
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 2 1Phase 3 1Not applicable 3

Drugs and treatments being studied

InterventionTrials
Abiraterone acetate1
Antiandrogen Therapy1
Gonadotropin-releasing Hormone Analog1
Hypofractionated Radiation Therapy1
Stereotactic Body Radiation Therapy1

Where trials are recruiting (top US states)

StateRecruiting trials
Arizona2
Florida1
Georgia1
Minnesota1
Wisconsin1

Top cities

Scottsdale, Arizona 2Albert Lea, Minnesota 1Atlanta, Georgia 1Eau Claire, Wisconsin 1Jacksonville, Florida 1La Crosse, Wisconsin 1Mankato, Minnesota 1Rochester, Minnesota 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Oligometastatic Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Prostate cancer 1234Stage III Prostate Cancer AJCC v8 19Localized Prostate Carcinoma 21Stage IVB Prostate Cancer AJCC v8 27Stage IVA Prostate Cancer AJCC v8 13Stage IV Prostate Cancer AJCC v8 14Stage IIC Prostate Cancer AJCC v8 5Stage IIB Prostate Cancer AJCC v8 3Stage II Prostate Cancer AJCC v8 12Stage I Prostate Cancer AJCC v8 10

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Oligometastatic Prostate Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.